Prelude Corp

SEC filing

Biotechnology · Laguna Hills, CA

Form D on EDGAR

Amount raised$5Msold at filing

Total offering$7.5M$2.5M still open

Investors in the raise1count reported to the SEC

FiledNov 6, 2025first sale Oct 30, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Alejandro B. SanchezDirector

Gerrit B. AdamsDirector

Andrew B. WadeExecutive Officer

Olav B. BergheimExecutive Officer, Director

Daniel B. ForcheExecutive Officer, Director

Derek B. MaetzoldDirector

Executive officers, directors and promoters as listed on the Form D.